Low Dose And High Dose Ketoconazole Demonstrate Similar Outcomes In Patients With Androgen-Independent Prostate Cancer
Fri, 15 Sep 2006 07:00 AM EST
... Patients on androgen deprivation therapy (ADT) for prostate cancer (CaP) eventually progress with a rising PSA. Definitions of androgen-independence vary, but usually include a documented castrate level of testosterone and failure of second-line hormonal therapy. One second-line therapy is ketoconazole, a broad-spectrum azole anti-fungal drug that inhibits gonadal and adrenal steroid synthesis. [click link for full article] ...
Related Topics
- Prostate Cancer
- Prostate
- Naltrexone
- Methylprednisolone
- Low Blood Pressure
- Biopsy of the Prostate
- High Cholesterol
- Metered Dose Inhaler
- Hemodialysis Dose and Adequacy
- Potassium
- Peritoneal Dialysis Dose and Adequacy
- Bone Cancer
- Cancers
- Low Vision
- Platelet Count
- Conjugated Estrogens and Medroxyprogesterone
- Low Vision & Blindness
- Hemoglobin
- Cholesterol
- Low Back Pain

Not Signed In -

